FDA orders Juul to remove all e-cigarettes from U.S. market

WASHINGTON — The Food and Drug Administration Thursday ordered all Juul electronic cigarettes removed from the U.S. market. It’s the biggest blow yet to the embattled company that is widely blamed for sparking a surge in teen vaping. 

The announcement Thursday by the FDA is part of a sweeping regulatory review of e-cigarettes, which faced little regulation until recently. 

The decision follows nearly two years of back and forth between the regulator and the San Francisco-based company, which had requested authorization for its tobacco and menthol-favored products to remain on the market.

The company failed to provide evidence that its products met legal standards, Michele Mital, acting director of the FDA’s Center for Tobacco Products, said in a statement.

“The FDA is tasked with ensuring that tobacco products sold in this country meet the standard set by the law, but the responsibility to demonstrate that a product meets those standards ultimately falls on the shoulders of the company,” she said. “However, the company did not provide that evidence and instead left us with significant questions. Without the data needed to determine relevant health risks, the FDA is issuing these marketing denial orders.”

Since last fall, the FDA has greenlighted a few e-cigarettes that account for a tiny share of the vaping market. To stay on the market, manufacturers must show their products help reduce the harm of smoking for adults, without appealing to kids.

Teen use of e-cigarettes skyrocketed more than 70% after Juul’s launch in 2015, leading the FDA to declare an “epidemic” of underage vaping among teenagers. 

Health experts said the unprecedented increase risked hooking a generation of young people on nicotine, an addictive chemical that is harmful to the developing brain.

Juul, which is partially owned by Altria Group Inc., has seen sales fall after halting all advertising and social media promotion and pulling most of its flavors except for menthol.